RLYB 8-K 2026-11-04

Rallybio Corp (RLYB) 8-K dated 2026-11-04 — accession 0001193125-26-447550.

Rallybio Corp (RLYB) is a biotechnology company listed on US.

Rallybio Corp filed a 8-K on 2026-11-04. Accession 0001193125-26-447550.

This 8-K covers: Director/officer change (Item 5.02), Shareholder vote results (Item 5.07), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported RLYB revenue for 2025-12-31 was $858.0K. Net income was -$9.0M. Revenue was up 43.0% from 2024-12-31 to 2025-12-31. RLYB currently screens at market cap $13.8M.

Not investment advice. The RLYB SEC hub lists recent forms. The stock page is the research view.